These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2345761)
21. Interactions of ketamine, naloxone and morphine in the rat. Fidecka S Pol J Pharmacol Pharm; 1987; 39(1):33-40. PubMed ID: 3671186 [TBL] [Abstract][Full Text] [Related]
22. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats. Maldonado R; Girdlestone D; Roques BP Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360 [TBL] [Abstract][Full Text] [Related]
23. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice. Farzin D Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester. Adams ML; Kalicki JM; Meyer ER; Cicero TJ Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108 [TBL] [Abstract][Full Text] [Related]
25. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Schulteis G; Yackey M; Risbrough V; Koob GF Pharmacol Biochem Behav; 1998 Jul; 60(3):727-31. PubMed ID: 9678657 [TBL] [Abstract][Full Text] [Related]
26. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions. Iwamoto ET; Loh HH; Way EL J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346 [TBL] [Abstract][Full Text] [Related]
27. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)]. Tremblay E; Colombel MC; Jacob J Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446 [TBL] [Abstract][Full Text] [Related]
28. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats. Sayin U; Atasoy S; Uzbay IT; Aricioğlu-Kartal F; Koyuncuoğlu H Pharmacol Res; 1998 Jul; 38(1):45-51. PubMed ID: 9697154 [TBL] [Abstract][Full Text] [Related]
29. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Gold LH; Stinus L; Inturrisi CE; Koob GF Eur J Pharmacol; 1994 Feb; 253(1-2):45-51. PubMed ID: 8013548 [TBL] [Abstract][Full Text] [Related]
30. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR). Navarro-Zaragoza J; Laorden ML; Milanés MV Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750 [TBL] [Abstract][Full Text] [Related]
31. FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Malin DH; Lake JR; Hammond MV; Fowler DE; Rogillio RB; Brown SL; Sims JL; Leecraft BM; Yang HY Peptides; 1990; 11(5):969-72. PubMed ID: 2284204 [TBL] [Abstract][Full Text] [Related]
32. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Funada M; Schutz CG; Shippenberg TS Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160 [TBL] [Abstract][Full Text] [Related]
33. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats. Marshall DC; Buccafusco JJ Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893 [TBL] [Abstract][Full Text] [Related]
34. Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus. Hooshmandi M; Hosseinmardi N; Janahmadi M; Khakpai F; Rohampour K; Doostmohammadi J Pharmacol Biochem Behav; 2017 Jul; 158():39-48. PubMed ID: 28583577 [TBL] [Abstract][Full Text] [Related]
35. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605 [TBL] [Abstract][Full Text] [Related]
36. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats. Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500 [TBL] [Abstract][Full Text] [Related]
37. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence? Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802 [TBL] [Abstract][Full Text] [Related]
38. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. Rosen MI; McMahon TJ; Woods SW; Pearsall HR; Kosten TR Eur J Pharmacol; 1996 Jul; 307(3):251-7. PubMed ID: 8836612 [TBL] [Abstract][Full Text] [Related]
39. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498 [TBL] [Abstract][Full Text] [Related]
40. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Sinchaisuk S; Ho IK; Rockhold RW Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]